NCT04903678View on ClinicalTrials.gov

Intrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma

NARecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

May 1, 2028

Study Completion Date

May 1, 2030

Conditions
Retinoblastoma, Extraocular
Interventions
DRUG

Melphalan

Melphalan is performed for intrathecal chemotherapy

Trial Locations (1)

Unknown

RECRUITING

Fudan Eye & ENT Hospital, Shanghai

All Listed Sponsors
collaborator

Zhongshan Ophthalmic Center, Sun Yat-sen University

OTHER

collaborator

Children's Hospital of Fudan University

OTHER

lead

Eye & ENT Hospital of Fudan University

OTHER